Indefinite Delivery Contract SPE2DX15D9934

The federal contract IDV awarded to DMS Pharmaceutical Group Inc. is a single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) under the SPE2DB program. The IDC has a ceiling value of $499,999,999 and is valid through November 2026, enabling the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide.

The contract covers an extensive portfolio of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various product categories such as injections, tablets, creams, auto-injectors, and specialty medications. The task orders under this IDC indicate that DMS Pharmaceutical Group is providing a diverse array of pharmaceutical items, including lidocaine, sodium chloride, medical vials, and epinephrine auto-injectors, to the DLA's Medical Supply Chain at the firm fixed prices specified in the delivery orders. As a woman-owned small business, DMS Pharmaceutical Group is positioned as a crucial supplier in the federal pharmaceutical supply chain, providing direct distribution of prescription drugs and pharmacy services to Department of Defense healthcare sites.